EPO Patents = 1

Trademarks = 1

Forward Citations = 7

Loading Chart...

7 inventors (with patents filed for the assignee):

Robert Alonso (4 out of 18 patents)

Peter Anthony Crooks (4 out of 97 patents)

Mark A Pimley (3 out of 8 patents)

4. David R Worthen (1 out of 6 patents)

5. Martin Stogniew (1 out of 49 patents)

6. Abeer M Al-Ghananeem (1 out of 4 patents)

7. Barry R Walker (1 out of 1 patent)

8. Peter Univ Kentucky College Of Pharmacy Crooks (0 patent)

4 patents: Sort by Forward Citations

1. 8501819 - Stabilized compositions of volatile alkylating agents and methods of using thereof (2013-08-06),

2. 8501818 - Stabilized compositions of alkylating agents and methods of using same (2013-08-06),

3. 8501817 - Stabilized compositions of alkylating agents and methods of using same (2013-08-06),

4. 8450375 - Stabilized compositions of volatile alkylating agents and methods of using thereof (2013-05-28),

Company Overview

Ceptaris Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing novel dermatology products. Their flagship product is a topical gel for the treatment of early-stage mycosis fungoides, a type of cutaneous T-cell lymphoma. Ceptaris is dedicated to improving the lives of patients with skin-related conditions through innovative therapies and research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#61 in Malvern, PA

#2,214 in Pennsylvania

#60,671 in US

Malvern, PA, United States of America

Ceptaris Therapeutics, Inc.

Forward Citations = 7

7 inventors:

Robert Alonso (4 out of 18 patents)

Peter Anthony Crooks (4 out of 97 patents)

Mark A Pimley (3 out of 8 patents)

4. David R Worthen (1 out of 6 patents)

5. Martin Stogniew (1 out of 49 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ceptaris Therapeutics, Inc.. Retrieved from https://idiyas.com/company/ceptaris-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]